The menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women.

Allogene Therapeutics, Inc. ALLO announced that the FDA has cleared its investigational new drug (IND) application to begin ...

Best-in-Class Design to Enhance Therapeutic Benefit and Expand Treatment Potential Across a Range of Autoimmune Disease Indications; Inno ...

Allogene Therapeutics (ALLO) announced that the U.S. Food and Drug Administration, FDA, has cleared its Investigational New Drug, IND, ...

Professor Christopher Denton discusses key aspects of the 2024 British Society for Rheumatology guideline on managing systemic sclerosis.

PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC) has cemented a collaboration with renowned cell therapy leaders Professors Georg Schett and Andreas Mackensen to initiate a Phase 1/2 trial ...

Exposure to various air pollutants, such as PM2.5 and nitrogen oxides, increases the risk for several autoimmune diseases, including psoriasis, lupus and rheumatoid arthritis, according to data ...

Explore new findings on frailty in systemic sclerosis, revealing its prevalence, dynamic progression, and impact on patient ...

During his departure announcement in 2024, Neil thanked his bosses for their patience when he took off “a day or two here and there battling everything from multiple sclerosis and COVID to ...

Sex-related differences in pulmonary complications were found among men vs women with SSc, specifically in the prevalence of ILD and SAD.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Pre-frail and frail patients with SSc showed 3.5 ...

1 Ophthalmology Department, Medical University of Bialystok, Bialystok, Poland 2 Department of Rheumatology and Internal Diseases, Medical University of Bialystok, Bialystok, Poland Purpose: Systemic ...